D181
Sigma

D₃ Dopamine Receptor from rat

recombinant, expressed in Escherichia coli, membrane suspension

MDL number

Descriptions

Analysis Note

Recommended assay conditions are supplied on the product data sheet. This is a bioassayed product. Actual concentration and specific binding capacity are provided with each lot.

Physical form

Membrane suspension in 50 mM Tris-HCl, pH 7.4, 10% glycerol, 1% BSA.

Properties

recombinant

expressed in Escherichia coli

form

membrane suspension

packaging

vial of 50 units

shipped in

dry ice

storage temp.

−70°C

References

Reference

Tang, et al., Pharmacological and functional characterization of D₂, D₃, and D₄ dopamine receptors in fibroblast and dopaminergic cell lines. J. Pharmacol. Exp. Ther. 268, 495, (1994) abstract

Bouthenet, et al., Localization of dopamine D₃ mRNA in the rat brain using in situ hybridization histochemistry: Comparison with dopamine D₂ mRNA. Brain Res. 564, 203, (1991) abstract

Sokoloff, et al., Molecular cloning and characterization of a novel dopamine receptor (D₃) as a target for neuroleptics. Nature 347, 146, (1990) abstract

Safety

WGK Germany